CXCL10 and tuberculosis: IP-10 has been found to be increased in the plasma of TB patients and its advantage is that it is expressed in high levels following Mtb antigen-specific stimulation in both active TB and LTBI, suggesting its potential as a biomarker for TB in children [21, 22].